Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

Name: Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.
Published: 2025
License: Public Domain

LucasBio · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

bkv infection, ebv infection, cmv infection, cmv, ebv, bkv, multi-virus, cmv-associated diseases, ebv-associated diseases, bkv-associated diseases, allogeneic hematopoietic stem cell transplantation, virus-specific t cells

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 892744
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.